Related Experiment Videos

Cardiac manifestations of the mucopolysaccharidoses

Circulation
|October 1, 1975
PubMed

Insights

Mucopolysaccharidoses (MPS) can affect the heart, with specific types showing distinct cardiovascular issues. Noninvasive cardiac tests help identify these problems, aiding in diagnosis and management of MPS-related heart conditions.

Area of Science:

  • Cardiology
  • Genetics
  • Pediatrics

Background:

  • Cardiovascular manifestations of mucopolysaccharidoses (MPS) are not well-defined.
  • MPS are a group of inherited metabolic disorders.
  • Cardiac involvement can significantly impact patient prognosis.

Purpose of the Study:

  • To characterize cardiovascular manifestations in children with various forms of MPS.
  • To evaluate the utility of noninvasive cardiac diagnostic techniques in MPS patients.
  • To correlate specific MPS types with cardiac abnormalities.

Main Methods:

  • Studied nine children with different types of MPS.
  • Utilized noninvasive cardiac diagnostic techniques, including echocardiography and electrocardiography.
  • Analyzed echocardiographic parameters such as mitral valve early diastolic closure velocities (MVEDC) and left atrial dimensions.

Main Results:

  • Type I H/S MPS patients showed mitral stenosis with calcification.
  • Type II A MPS patients exhibited impaired left ventricular function and myocardial damage.
  • Type VI A MPS patients presented with both aortic and mitral valve involvement.
  • No cardiac abnormalities were found in Type III A and IV MPS patients.

Conclusions:

  • Noninvasive cardiac studies are valuable for evaluating cardiovascular health in MPS.
  • Specific MPS types (I H/S, VI A, II A) are associated with distinct cardiac abnormalities.
  • Early detection and monitoring of cardiac issues in MPS are crucial for patient care.

Related Concept Videos